PolaSight raises USD 100,000

A University of Bern spin-off, PolaSight has developed PolaOne, a label-free imaging device that produces a tissue map in one minute during cancer surgery. The start-up received a USD 100,000 investment from Constructor Capital at the Demo Day of Constructor Start.

Announced on
Round
Undisclosed round
Amount
USD 100,000
Location
canton of Vaud
Sector
Health & medtech, Deep tech

Investors

  • Constructor Capital

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic